Literature DB >> 17005099

Cerebellar lesions in tuberous sclerosis complex: neurobehavioral and neuroimaging correlates.

Thomas J Eluvathingal1, Michael E Behen, Harry T Chugani, James Janisse, Bruno Bernardi, Pulak Chakraborty, Csaba Juhasz, Otto Muzik, Diane C Chugani.   

Abstract

We assessed the structural and functional imaging features of cerebellar lesions and their neurobehavioral correlates in a large cohort of patients with tuberous sclerosis complex. A consecutive series of 78 patients with tuberous sclerosis complex underwent magnetic resonance imaging (MRI) and positron emission tomography (PET) studies with [(18)F]fluorodeoxyglucose (FDG) and alpha-[(11)C]methyl-l-tryptophan (AMT) as part of their evaluation for epilepsy surgery. Neurobehavioral assessment included the Gilliam Autism Rating Scales (GARS) and the Vineland Adaptive Behavior Scales (VABS). Twenty-one patients (27%) had cerebellar lesions (10 boys; mean age 9 +/- 8 years; 9 had right-sided, 10 had left-sided, and 2 had bilateral cerebellar lesions). The lesions showed decreased glucose metabolism (0.79 +/- 0.10) and increased (1.04 +/- 0.10) AMT uptake compared with the normal (nonlesional) cerebellar cortex. Comparisons between patients with (n = 20) and without (n = 57) a cerebellar lesion on neurobehavioral functioning, controlling for the number and location of cortical tubers, revealed that the cerebellar lesion group had higher overall autistic symptomatology. Within-group analyses of the cerebellar lesion group revealed that children with right-sided cerebellar lesions had higher social isolation and communicative and developmental disturbance compared with children with left-sided cerebellar lesions. The side of the cerebellar lesion was not related to adaptive behavior functioning. These findings provide additional empiric support for a role of the cerebellum in autistic symptomatology. Further investigation of the potential role of the right cerebellum in autism, particularly with regard to the dentatothalamofrontal circuit, is warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005099     DOI: 10.1177/08830738060210100301

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  38 in total

Review 1.  α-[¹¹C]-methyl-L-tryptophan PET for tracer localization of epileptogenic brain regions: clinical studies.

Authors:  Ajay Kumar; Eishi Asano; Harry T Chugani
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

Review 2.  Consensus paper: pathological role of the cerebellum in autism.

Authors:  S Hossein Fatemi; Kimberly A Aldinger; Paul Ashwood; Margaret L Bauman; Charles D Blaha; Gene J Blatt; Abha Chauhan; Ved Chauhan; Stephen R Dager; Price E Dickson; Annette M Estes; Dan Goldowitz; Detlef H Heck; Thomas L Kemper; Bryan H King; Loren A Martin; Kathleen J Millen; Guy Mittleman; Matthew W Mosconi; Antonio M Persico; John A Sweeney; Sara J Webb; John P Welsh
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

Review 3.  Potential for treatment of severe autism in tuberous sclerosis complex.

Authors:  Tanjala T Gipson; Gwendolyn Gerner; Mary Ann Wilson; Mary E Blue; Michael V Johnston
Journal:  World J Clin Pediatr       Date:  2013-08-08

Review 4.  Disentangling the heterogeneity of autism spectrum disorder through genetic findings.

Authors:  Shafali S Jeste; Daniel H Geschwind
Journal:  Nat Rev Neurol       Date:  2014-01-28       Impact factor: 42.937

5.  Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice.

Authors:  John J McMahon; Wilson Yu; Jun Yang; Haihua Feng; Meghan Helm; Elizabeth McMahon; Xinjun Zhu; Damian Shin; Yunfei Huang
Journal:  Neurobiol Dis       Date:  2014-10-12       Impact factor: 5.996

Review 6.  Connecting genes to brain in the autism spectrum disorders.

Authors:  Brett S Abrahams; Daniel H Geschwind
Journal:  Arch Neurol       Date:  2010-04

7.  Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex.

Authors:  Àlex Rovira; María Luz Ruiz-Falcó; Elena García-Esparza; Eduardo López-Laso; Alfons Macaya; Ignacio Málaga; Élida Vázquez; Josefina Vicente
Journal:  J Neurooncol       Date:  2014-04-27       Impact factor: 4.130

8.  Magnetic resonance imaging and diffusion-weighted imaging of normal-appearing white matter in children and young adults with tuberous sclerosis complex.

Authors:  Sahayini Arulrajah; Gulhan Ertan; Lori Jordan; Aylin Tekes; Elizabeth Khaykin; Izlem Izbudak; Thierry A G M Huisman
Journal:  Neuroradiology       Date:  2009-07-15       Impact factor: 2.804

Review 9.  A developmental and genetic classification for midbrain-hindbrain malformations.

Authors:  A James Barkovich; Kathleen J Millen; William B Dobyns
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

10.  Defining the role of cerebellar Purkinje cells in autism spectrum disorders.

Authors:  Anamaria Sudarov
Journal:  Cerebellum       Date:  2013-12       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.